Press Releases

• 7,500 vaccination appointments are available for specific vulnerable groups on 11 and 12 April.
• Until the 9th April, a total of 183,225 vaccinations were carried out (130.937 with the 1st dose and 52.288 with the 2nd dose.)
• 10,318 individuals belonging to vulnerable groups and 654 bed-bound people received the first dose of the vaccine.
• Vaccination in closed structures began – The 1st dose of the vaccine was administered to 158 people in the Central Prisons.

The implementation of the National Vaccination Plan against COVID-19 continues, with priority for arranging an appointment being given to specific groups of people with increased risk of serious illness. From Sunday, 11 April at 8 a.m., until Monday, 12 April at 8 p.m., 7.500 appointments for vaccination with Pfizer and AstraZeneca vaccines will be made available through the Vaccination Portal in all districts, proportionally, based on the availability for each type of vaccine.

Priority for vaccination will be given to 7,200 patients, registered with the General Health System as determined on the basis of scientific criteria by the Scientific Advisory Committee and the Ad Hoc Committee for the prioritization of vulnerable groups. Scientific companies and the Cyprus Medical Association as well as Patients’ Associations through the Federation of Patients Associations of Cyprus contributed significantly in the preparation of the registers. It is noted that most requests by Specialized doctors, received after the deadline, to include additional patients have been taken into account, while those not included will be vaccinated at a later stage.

More specifically, patients belonging to the following groups, regardless of age, will be able to plan their vaccination on 11 and 12 April:

• Severe Chronic Respiratory Disease
• Severe Chronic Renal Disease
• Severe Cardiac failure
• Severe Cardiovascular Disease
• Congenital heart disease following surgical correction with significant residual damage or uncorrected congenital heart disease with significant residual damage.
• Patients with a history of transplantation
• Patients with immunodeficiencies, oncological cases and haematological malignancies
• Patients with quadriplegia – neurological diseases with pulmonary problems
• Individuals with Down Syndrome
• Patients receiving biological agents, who have been approved upon a request to the Pharmaceutical Services

• Patients with hemoglobinopathy.

Patients belonging to the above groups will be informed of the priority they will have for an appointment arrangement also by means of a written telephone message, provided that their contact details are complete and correct.

It is recalled that patients who are not beneficiaries of the General Health System (GESY) or receive medicines that fall into these categories from the private sector, will be given priority for vaccination, based on the above criteria, upon confirmation by their treating physician and after sending a relevant e-mail to the e-mail address emvoliasmos.eidikes@moh.gov.cy. The email should express the patient’s interest for vaccination, quoting his/her Identity Number/Identification Document Number, contact telephone number, stating the specific group he /she belongs to and attaching the relevant certificate by the treating physician.

By the 9th April, 183,225 vaccinations were administered out of which 130.937 concern the administration of the 1^st doseand 52.288concern the administration of both doses. The 1st dose of the vaccine was administered to 10.318 individuals belonging to the vulnerable groups and 654 to bedridden individuals. At the same time, vaccination has begun in closed structures and will continue in the next few days. Already, 158 individuals in the Central Prisons have been vaccinated with the 1st dose.

MPO